Tag: congenital heart disease (chd) market demand

  • 2024-2033 Congenital Heart Disease (CHD) Market Outlook: Unlocking Growth Potential

    2024-2033 Congenital Heart Disease (CHD) Market Outlook: Unlocking Growth Potential

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Congenital Heart Disease (CHD) Market from 2024 to 2033?
    The congenital heart disease market has seen robust growth recently. It will expand from $4.03 billion in 2023 to $4.42 billion in 2024, with a CAGR of 9.7%. This growth can be attributed to the rising prevalence of risk factors like obesity and smoking, advancements in diagnostic technologies, an aging population, awareness campaigns, enhanced reimbursement policies, and increased R&D investment.

    The congenital heart disease (CHD) market is projected to grow significantly, expected to reach $6.43 billion by 2028 at a CAGR of 9.8%. Growth factors include improved access to healthcare in developing regions, ongoing innovation in cardiac imaging technologies, awareness campaigns for early detection, increased global healthcare spending, and the advancement of personalized medicine. Major trends include the adoption of minimally invasive surgical techniques, increased use of telemedicine for monitoring, demand for personalized treatment, innovative implantable devices, and AI integration in diagnostics and therapy.

    Claim Your Free Sample of the Global Congenital Heart Disease (CHD) Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15545&type=smp

    What Key Factors Are Fueling the Growth of the Congenital Heart Disease (CHD) Market?
    The rise in maternal diabetes cases is expected to boost the congenital heart disease (CHD) market. Maternal diabetes, which arises during pregnancy, can affect fetal heart development and increase the risk of congenital heart disease in infants. This rise is linked to lifestyle changes and increased obesity rates among women. For instance, the CDC reported a rise in gestational diabetes among pregnant mothers, from 6.0% in 2020 to 8.3% in 2021. Therefore, the increase in maternal diabetes cases is driving the congenital heart disease (CHD) market.

    What Are the Major Segments of the Congenital Heart Disease (CHD) Market?
    1) By Type: Heart Valve Defects; Heart Wall Defects; Blood Vessel Defects; Other Types
    2) By Diagnosis: Electrocardiogram; Chest X-ray;  Echocardiogram; Transesophageal Echocardiogram; Pulse Oximetry; Exercise Stress Test; Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI); Cardiac Catheterization; Other Diagnosis
    3) By Treatment: Interventional Cardiology; Cardiac Surgery; Telemedicine; Medication Management; Lifestyle Modifications
    4) By Age Group: Infants; Children; Adolescents; Adults
    5) By Application: Hospitals And Clinics; Diagnostic Centers; Ambulatory Surgical Centers; Research And Academic Institutions

    What New Trends Are Transforming the Congenital Heart Disease (CHD) Market?
    Leading firms in the congenital heart disease market are innovating non-surgical heart valves to enhance patient care. For example, in February 2023, Medtronic reintroduced its Harmony Transcatheter Pulmonary Valve System, offering a minimally invasive option for patients with specific heart anomalies.

    Order Now for Fast Delivery of Your Congenital Heart Disease (CHD) Market Report!
    https://www.thebusinessresearchcompany.com/report/congenital-heart-disease-chd-global-market-report

    Which Regions Are Driving Growth in the Congenital Heart Disease (CHD) Market?
    North America was the largest region in the congenital heart disease (CHD) market in 2023. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Congenital Heart Disease (CHD) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the congenital heart disease (chd) market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Congenital Heart Disease (CHD) Market Include

    1. Congenital Heart Disease (CHD) Market Executive Summary
    2. Congenital Heart Disease (CHD) Market Segments
    3. Congenital Heart Disease (CHD) Market Size And Template Market Growth Rate
    4.  Key Congenital Heart Disease (CHD) Market Trends
    5. Major Congenital Heart Disease (CHD) Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Congenital Heart Disease (CHD) Market
    26. Top Congenital Heart Disease (CHD) Companies
    27. Congenital Heart Disease (CHD) Market Opportunities And Strategies
    28. Congenital Heart Disease (CHD) Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Cardiovascular Ultrasound Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report

    Cardiovascular Surgery Devices And Equipment Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

    Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How Is The Congenital Heart Disease (CHD) Market Expected To Grow Through 2024-2033

    How Is The Congenital Heart Disease (CHD) Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Congenital Heart Disease (CHD) Global Market Report 2023, the congenital heart disease (CHD) market is expected to show promising growth in the forecast period.

    Market Overview

    • 2023 Market Size: $4.03 billion
    • 2024 Projected Market Size: $4.42 billion
    • CAGR (2023-2024): 9.7%

    The congenital heart disease (CHD) market has experienced significant growth due to advancements in diagnostic and therapeutic technologies, increased awareness, and improved healthcare policies. The market is expected to continue expanding, reaching $6.43 billion by 2028.

    Future Market Growth

    • 2028 Projected Market Size: $6.43 billion
    • CAGR (2024-2028): 9.8%

    The expected growth is driven by increasing access to healthcare in developing regions, ongoing innovations in cardiac imaging, and rising global healthcare expenditures.

    View More On The Congenital Heart Disease (CHD) Market Report 2024 –
    https://www.thebusinessresearchcompany.com/report/congenital-heart-disease-chd-global-market-report

    Key Drivers and Trends

    • Maternal Diabetes Impact: The rise in maternal diabetes is a major driver for market growth. Gestational diabetes can increase the risk of congenital heart disease in infants. According to the CDC, the incidence of gestational diabetes increased from 6.0% to 8.3% from 2016 to 2021, highlighting the growing impact on CHD prevalence.
    • Technological Innovations: The adoption of non-surgical heart valves, like the Harmony Transcatheter Pulmonary Valve (TPV) System by Medtronic, is transforming CHD treatment. This minimally invasive valve offers a non-surgical solution for patients with right ventricular outflow tract (RVOT) anomalies, improving patient outcomes and quality of life.
    • Strategic Acquisitions: Venus MedTech’s acquisition of Cardiovalve Ltd. in December 2021 for $300 million is a significant market development. This acquisition enhances Venus MedTech’s capabilities in mitral and tricuspid valve replacement, positioning it as a leading player in structural heart treatments.

    Market Segmentation

    • By Type:
      • Heart Valve Defects
      • Heart Wall Defects
      • Blood Vessel Defects
      • Other Types
    • By Diagnosis:
      • Electrocardiogram
      • Chest X-ray
      • Echocardiogram
      • Transesophageal Echocardiogram
      • Pulse Oximetry
      • Exercise Stress Test
      • Cardiac Computed Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
      • Cardiac Catheterization
      • Other Diagnosis
    • By Treatment:
      • Interventional Cardiology
      • Cardiac Surgery
      • Telemedicine
      • Medication Management
      • Lifestyle Modifications
    • By Age Group:
      • Infants
      • Children
      • Adolescents
      • Adults
    • By Application:
      • Hospitals and Clinics
      • Diagnostic Centers
      • Ambulatory Surgical Centers
      • Research and Academic Institutions

    Regional Insights

    • North America: Was the largest market in 2023 due to advanced healthcare infrastructure and high adoption of new technologies.

    Conclusion
    The congenital heart disease market is poised for continued growth driven by technological advancements, increased awareness of maternal diabetes, and strategic industry moves. Innovations in non-surgical treatments and acquisitions of key players are likely to drive further expansion and improvements in patient care.

    Request A Sample Of The Global Congenital Heart Disease (CHD) Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15545&type=smp